These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28771321)

  • 1. Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System.
    Cannaert A; Franz F; Auwärter V; Stove CP
    Anal Chem; 2017 Sep; 89(17):9527-9536. PubMed ID: 28771321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay.
    Cannaert A; Storme J; Franz F; Auwärter V; Stove CP
    Anal Chem; 2016 Dec; 88(23):11476-11485. PubMed ID: 27779402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-Based Detection of Cannabinoids in Serum and Plasma Samples.
    Cannaert A; Storme J; Hess C; Auwärter V; Wille SMR; Stove CP
    Clin Chem; 2018 Jun; 64(6):918-926. PubMed ID: 29559524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine.
    Mohr AL; Ofsa B; Keil AM; Simon JR; McMullin M; Logan BK
    J Anal Toxicol; 2014 Sep; 38(7):427-31. PubMed ID: 24908262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the consumption of synthetic cannabinoids among teenagers by the analysis of herbal blends and urine samples.
    Fabregat-Safont D; Ibáñez M; Baquero A; Sancho JV; Hernández F; Haro G
    J Pharm Biomed Anal; 2020 Jul; 186():113298. PubMed ID: 32325401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
    Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
    Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
    Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
    Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.
    Franz F; Angerer V; Jechle H; Pegoro M; Ertl H; Weinfurtner G; Janele D; Schlögl C; Friedl M; Gerl S; Mielke R; Zehnle R; Wagner M; Moosmann B; Auwärter V
    Clin Chem Lab Med; 2017 Aug; 55(9):1375-1384. PubMed ID: 28130957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
    Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
    J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Jang M; Kim IS; Park YN; Kim J; Han I; Baeck S; Yang W; Yoo HH
    Anal Bioanal Chem; 2016 Jan; 408(2):503-16. PubMed ID: 26514671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Analysis of Synthetic Cannabinoid Metabolites in Urine of Individuals Suspected of Driving Impaired.
    Davies BB; Bayard C; Larson SJ; Zarwell LW; Mitchell RA
    J Anal Toxicol; 2016 Mar; 40(2):89-96. PubMed ID: 26687103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.